Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network

Racial differences in three major NHL subtypes: Descriptive epidemiology

(2015) Yang Li et al.   Cancer Epidemiology

The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras

(2014) Chadi Nabhan et al.   AMERICAN JOURNAL OF HEMATOLOGY

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014) M. Dreyling et al.   ANNALS OF ONCOLOGY

Determining disease prevalence from incidence and survival using simulation techniques

(2014) Simon Crouch et al.   Cancer Epidemiology

Control of data quality for population-based cancer survival analysis

(2014) Ruoran Li et al.   Cancer Epidemiology

Putting the Clinical and Biological Heterogeneity of Non-Hodgkin Lymphoma into Context

(2014) O. A. O'Connor et al.   CLINICAL CANCER RESEARCH

External Validity of a Trial Comprised of Elderly Patients With Hormone Receptor-Positive Breast Cancer

(2014) W. van de Water et al.   JNCI-Journal of the National Cancer Institute

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study

(2014) Milena Sant et al.   LANCET ONCOLOGY

Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort

(2014) A G Smith et al.   BMJ Open

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

(2013) M. Dreyling et al.   ANNALS OF ONCOLOGY

Population-based data from the Swedish Colon Cancer Registry

(2013) K. Kodeda et al.   BRITISH JOURNAL OF SURGERY

Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved?

(2013) Kat Kwiatkowski et al.   CANCER

A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP-Rituximab versus CHOP + 131Iodine--Tositumomab

(2013) O. W. Press et al.   CLINICAL CANCER RESEARCH

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

(2013) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Patient Income Level and Cancer Clinical Trial Participation

(2013) Joseph M. Unger et al.   JOURNAL OF CLINICAL ONCOLOGY

Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?

(2013) Anne-Sophie AS Michallet et al.   Journal of Hematology & Oncology

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

(2013) David Cunningham et al.   LANCET

First-Line Treatment Patterns and Clinical Outcomes in Patients With HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer From registHER

(2013) D. Tripathy et al.   ONCOLOGIST

Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma

(2013) Soham Puvvada et al.   Cancer Genetics

Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research

(2013) N. Freemantle et al.   BMJ-British Medical Journal

Survival of patients with marginal zone lymphoma

(2012) Adam J. Olszewski et al.   CANCER

Barriers to therapeutic clinical trials enrollment: Differences between African-American and white cancer patients identified at the time of eligibility assessment

(2012) Lynne Penberthy et al.   Clinical Trials

Comparative Effectiveness Research in Oncology Methodology: Observational Data

(2012) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Methods in Comparative Effectiveness Research

(2012) Katrina Armstrong   JOURNAL OF CLINICAL ONCOLOGY

Effect of Patient Socioeconomic Status on Access to Early-Phase Cancer Trials

(2012) Aisyah Mohd Noor et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Trials Versus the Real World in the United States

(2011) Waddah B. Al-Refaie et al.   ANNALS OF SURGERY

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

(2011) E. Campo et al.   BLOOD

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network

(2011) A Smith et al.   BRITISH JOURNAL OF CANCER

Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project

(2011) R. Marcos-Gragera et al.   HAEMATOLOGICA

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

(2010) M. Sant et al.   BLOOD

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research

(2009) Alexandra Smith et al.   BRITISH JOURNAL OF HAEMATOLOGY

Commentary: External validity of results of randomized trials: disentangling a complex concept

(2009) P. M Rothwell   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The 2008 WHO classification of lymphomas: implications for clinical practice and translational research

(2009) E. S. Jaffe   Hematology-American Society of Hematology Education Program

Cancer survival in England and Wales at the end of the 20th century

(2008) B Rachet et al.   BRITISH JOURNAL OF CANCER

Analysis of patient selection and external validity in the Swedish contribution to the COLOR trial

(2008) Martin Janson et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES